Three experts discuss the increased mortality risk for patients with diabetic retinopathy, available screening tools, and counseling patients during eye exams.
Regardless of age at diagnosis or duration of disease, patients with diabetes who underwent intensive glucose lowering had lower risk for vascular events and death, according to a post hoc analysis ...
As global markets show signs of optimism with cooling inflation and strong earnings reports, major U.S. stock indexes have rebounded, particularly favoring value stocks over growth shares. In this ...
Analysts at market.us are predicting the Generative AI in Healthcare Market to reach US$17.2 billion by 2032, growing at a CAGR of 37% along the way. Researchers at Technavio see an even bigger future ...
today announced that the first patient has been dosed in the OCU200 Phase 1 clinical trial for diabetic macular edema (DME). "OCU200 has the potential to change the treatment landscape for DME, ...
Innovative Imaging Technologies and AI Integration Propel the Clinical Trial Imaging Market Growth, Revolutionizing Drug Development and Patient Safety Monitoring.Pune, Jan. 15, 2025 (GLOBE NEWSWIRE) ...